InSphero
PrivateLast Round
Series D
Mar 31, 2023
Total Funding Raised
$26.49M
Company Overview
InSphero is a biotechnology company that develops and provides 3D cell-based assay and organ-on-a-chip technology designed to deliver biologically relevant insights for in vitro testing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Medical Imaging
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InSphero Comparables
Compare InSphero with similar companies based on industry and business-model similarity.
InSphero Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Mar 31, 2023 | ||||
| Grant | Jan 23, 2023 | ||||
| VC Round | Jun 13, 2018 | ||||
| Series C | Jul 8, 2015 | ||||
| Series B | Jun 18, 2013 | ||||
Series A | Aug 5, 2010 |
InSphero Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eurostars SME programme | Grant |
| Innosuisse | Grant |
| Redalpine | VC Round, Series A |
| Bpifrance | Grant |
| OCCIDENT | Series D |
| Zurcher Kantonalbank | VC Round, Series A |
| ZEISS Ventures | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2025
Monthly visitors grew 54% MoM.
- Mar 31, 2023
ZEISS Ventures led the Series D round.
Recent news
Latest coverage and updates
- hiresAug 17, 2026
InSphero AG promotes Dr. Olivier Frey from Vice President of Technologies and Platforms to Chief Operating Officer and Chief Technology Officer in Switzerland on Aug 17th '26, where he leads technology strategy, operational efficiency, digitalization, and automation.
- promotesAug 17, 2026
On Aug 17th '26, InSphero AG promotes Olivier Frey, previously Vice President of Technologies and Platforms, to Chief Operating Officer and Chief Technology Officer, where he leads technology strategy, operational efficiency, and automation.
InSphero Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about InSphero's valuation, stock price, and market status.
Is InSphero a public or private company?
InSphero is a private company.
What is the current stock price of InSphero?
InSphero is a private company, so its shares have no public market price. Caplight tracks InSphero's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is InSphero worth (valuation)?
Valuation information for InSphero is not publicly available.
Can I buy InSphero stock?
InSphero shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was InSphero's last funding round?
InSphero's most recent funding round was Series D on March 31, 2023.
Who are the main investors in InSphero?
Key investors in InSphero include Redalpine, ZEISS Ventures.
Will InSphero IPO soon?
No public IPO plans have been announced for InSphero.
How can I track InSphero secondary market activity?
Caplight tracks bids, offers, and trades in InSphero's shares on secondary markets.